CN114561467B - MET fusion gene detection method, kit and probe library - Google Patents

MET fusion gene detection method, kit and probe library Download PDF

Info

Publication number
CN114561467B
CN114561467B CN202210152016.9A CN202210152016A CN114561467B CN 114561467 B CN114561467 B CN 114561467B CN 202210152016 A CN202210152016 A CN 202210152016A CN 114561467 B CN114561467 B CN 114561467B
Authority
CN
China
Prior art keywords
artificial sequence
dna
probe
met
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210152016.9A
Other languages
Chinese (zh)
Other versions
CN114561467A (en
Inventor
郑燕影
陈劼
张珦
孙怡
应葳
储乐乐
逄娇慧
白娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Shihe Gene Biotechnology Co ltd
Jiangsu Provincial Hospital of Chinese Medicine
Original Assignee
Nanjing Shihe Gene Biotechnology Co ltd
Jiangsu Provincial Hospital of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Shihe Gene Biotechnology Co ltd, Jiangsu Provincial Hospital of Chinese Medicine filed Critical Nanjing Shihe Gene Biotechnology Co ltd
Priority to CN202210152016.9A priority Critical patent/CN114561467B/en
Publication of CN114561467A publication Critical patent/CN114561467A/en
Application granted granted Critical
Publication of CN114561467B publication Critical patent/CN114561467B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention develops a method for capturing a specific MET fusion gene sequence based on hybridization selection, by adopting the method, thousands of times of enriched MET fusion gene DNA fragments can be obtained, the enriched MET fusion gene fragment sample can be selectively applied to various gene detection technologies, and particularly can be applied to detection of aspects of gene mutation, deletion, amplification, fusion and the like by using a next generation sequencing technology, so that high-efficiency and accurate results can be obtained.

Description

MET fusion gene detection method, kit and probe library
Technical Field
The invention relates to a detection method, a kit and a probe library of a MET fusion gene, belonging to the technical field of gene sequencing.
Background
The MET gene is located on the long arm of human chromosome 7, encodes hepatocyte growth factor receptor HGF, and has tyrosine kinase activity. After MET binds HGF, autophosphorylation occurs and activates multiple signaling pathways such as downstream PI3K/ALK, RAS-MAPK, β -catenin signaling pathways. The MET gene is associated with a variety of oncogene products and regulatory proteins, and is involved in the regulation of cell information transduction, cytoskeletal rearrangement, an important regulator of cell proliferation, differentiation, motility, angiogenesis and tissue regeneration. In healthy adult cells, HGF/MET expression levels are low, except at tissue injury, with little activity. In cancer cells, however, HGF/MET is often overexpressed, and this overexpression is associated with tumorigenesis, metastasis, and a poor overall prognosis.
Oncogenic activation of MET signaling is found in many malignancies, including digestive system tumors, hematopoietic system tumors, osteosarcomas, melanomas, gliomas, and the like. HGF/MET pathway abnormalities are associated with the development and metastasis of tumors and induce the development of drug resistance, including MET gene rearrangement, gene mutation, gene amplification, and protein overexpression. MET exists predominantly in a fused form in gliomas. Four MET inhibitors, respectively, teprotinib, carbamazepine, cabotinib, and crizotinib, have been approved by the FDA at present. It is reported in the literature that glioblastoma patients with PTPRZ1-MET fusion were detected with a2 month response to treatment with the MET inhibitor crizotinib and that tumors continued to shrink.
MET fusion occurs at about 2.8-5% in gliomas and about 10% in recurrent childhood gliomas. There are several MET fusion partner genes in brain gliomas, with PTPRZ1 accounting for about 36-60%; secondly, CAPZA2, accounting for about 18-33%; further, ST7, TPR, PTN are 27%, 9%, 5%, respectively; in addition, TRIM24, TFG, CLIP2, DNAH14, PHTF2, HLA-DRB1, CFTR, HLA-DRB5, RRBP1, etc. have been reported. The incidence of PTPRZ1-MET is about 10-16% from the high grade adult glioma overall.
Disclosure of Invention
The invention provides a detection method of MET fusion genes based on NGS sequencing, which can accurately detect the occurrence of MET fusion genes under the condition of low sample size, can detect and obtain reported fusion forms and can detect and obtain unreported new fusion.
The probe library for MET family fusion gene mutation includes one probe with nucleotide sequence as shown in SEQ ID No.1-197 or one probe with the same function as the probe.
Preferably: the probe library includes all of the probes described above.
Preferably: the probes with the same function refer to probes with the same hybridization capturing function by replacing and/or deleting and/or adding one or more nucleotides on any one of the probes with SEQ ID NO. 1-197.
Preferably: the probe having the same function has 80% or more of the same base as the original probe, more preferably 90% or more of the same base, still more preferably 95% or more of the same base.
A method for detecting a MET fusion gene, comprising:
step 1, obtaining DNA of a sample to be detected;
step 2, hybridizing the DNA of the sample to be detected with the probe, capturing, performing NGS sequencing, comparing the on-machine data with the reference genome data, and analyzing to obtain the information of the MET fusion gene;
wherein the probe refers to the probe library.
The sample to be tested is derived from a cell, tissue or body fluid sample.
The DNA of the sample to be detected is cDNA obtained by direct extraction or synthesis after mRNA extraction.
The DNA of the sample to be detected is fragmented and has a length of 150-600 bp.
The detection method is used for non-therapeutic and diagnostic applications.
A detection kit comprises the probe library.
The kit also comprises: and the DNA extraction reagent is used for extracting the DNA of the sample to be detected.
The kit also comprises: the RNA extraction reagent is used for extracting mRNA of a sample to be detected; a reverse transcription kit for reverse transcribing the extracted mRNA into cDNA.
Advantageous effects
Compared with traditional detection means such as FISH, the detection method based on the NGS for detecting the MET fusion has the advantages that the NGS technology can detect the MET fusion in a tissue sample, and can detect the MET fusion state through liquid samples such as blood plasma and hydrothorax;
in addition to detecting common MET fusion types, NGS technologies can also detect rare MET fusion types; meanwhile, compared with the traditional detection means, the NGS can also clearly fuse partner genes, and can detect a plurality of other MET gene variation types, thereby assisting in the formulation of clinical targeted treatment schemes.
Drawings
FIG. 1 is an exemplary process flow diagram of the present invention wherein target gene clusters are enriched and used for gene fusion detection based on next generation sequencing technology.
FIG. 2 is a schematic representation of the design of an exon-adjacent intron probe of the present invention.
FIG. 3 is a graph comparing sequencing results of intron region probe design with conventional probe design.
FIG. 4 is a graph comparing the sequencing results of exon adjacent intron design with conventional probe design.
Detailed Description
The invention discloses mutation information of MET fusion genes to be detected, wherein 'fusion mutation' refers to chimeric genes formed by connecting coding regions of two or more genes end to end under the control of the same set of regulatory sequences (including promoters, enhancers, ribosome binding sequences, terminators and the like).
Common MET fusion partner genes comprise PTPRZ1, CAPZA2, ST7, TPR, PTN, TRIM24, TFG, CLIP2 and the like, and if the rare fusion is likely to be missed by using a traditional detection means, the fusion can not be distinguished by the traditional FISH and IHC detection. IHC diagnostic kit of MET is still in clinical research stage, and the fusion advantage of NGS detection MET is prominent. At present, MET fusion studies are relatively few, fusion cleavage sites are not fixed, but a few introns are often generated in front of the gene kinase domain, and the traditional probe coverage pattern is incomplete for the introns and uneven for the introns, which may also cause missed detection of MET genes. The probe designed by the research optimizes on the basis of the traditional probe, and not only covers the whole area of the exon region of the gene, but also covers the whole area of the important intron region of the gene uniformly so as to avoid common and rare fusion omission.
The present invention provides a method for enriching MET fusion gene fragments. Specifically, the method of the present invention comprises: extracting genomic DNA or mRNA from a cell, body fluid or tissue sample of a mammal such as a human, and treating or synthesizing cDNA to obtain fragmented double-stranded DNA as a DNA sample library; in addition, designing DNA probes hybridized with the MET fusion gene aiming at the MET fusion gene fragments to be enriched, and screening a plurality of probes from the DNA probes as a DNA probe library; then, the DNA sample library is hybridized with a DNA probe library, so that MET fusion gene DNA fragments are enriched from the DNA sample library. According to an embodiment of the present invention, each probe in the DNA probe pool may be biotinylated first, then after hybridization, the hybridization product is adsorbed with streptavidin magnetic beads, and then the enriched MET fusion gene fragment is released from the magnetic beads. After the adaptation treatment, the next generation sequencing gene can be adopted to detect the gene structure mutation of the MET fusion gene segment so as to confirm various mutations of the MET fusion gene.
Regarding the design of the probe pool in this patent:
the capture specificity is affected by various factors, such as poor design of capture probes, poor capture conditions, insufficient blocking of repetitive sequences in genomic DNA, and improper ratio of genomic DNA to capture probes, which can affect the capture specificity, sensitivity, sequencing coverage, and other results. In order to achieve high enrichment and low off-target rate of the target gene, a person skilled in the art needs to make a lot of experiments about the type, length, sequence, hybridization conditions, etc. of the probe, and needs to obtain the optimal parameter combination through creative exploration work, and whether the same effect can be achieved is not proved by corresponding evidence, which is unexpected by the person skilled in the art. Meanwhile, when a sample with mutation is detected, the proportion of the mutation sample in the tissue sample can be different from one individual to another, so that if the abundance of the mutation sample is low, the problem that the probe cannot be hybridized with the mutated fragment accurately is easily caused, the sensitivity of detection is low, and the probe sequence needs to be tested and searched.
In addition to all gene probe designs involving commonality factors, the characteristics of the MET fusion gene itself have led to additional considerations in the process of probe design. According to the statistics of the commemorative Stonex-Katelin cancer center, the MET fusion incidence rate of the brain glioma is about 0.1%, wherein MET gene fusion breaking sites are mainly located in the exon1-exon2 and exon13-exon15 intervals, and on the basis of ensuring the specificity of probes, probes located near the breaking sites are required to be optimally designed so as to improve detection accuracy.
The steps of processing the sample used in the present invention are as follows:
extraction and fragmentation of DNA samples
The commercial DNA extraction kit is adopted to extract DNA from tissue samples, plasma samples, ascites samples or hydrothorax samples, quantitative quality control is carried out through Nanodrop and Qubit, and for the tissue and hydrothorax DNA samples, ultrasonic crushing is needed due to longer DNA fragments.
Purification and end repair of DNA samples
Adding enzyme-free water into the DNA sample obtained in the steps to fill up to 100ul, adding 150ul of Axygen beads, magnetically separating to remove supernatant after resuspension, adding 200ul of 80% ethanol, washing on a magnetic rack, incubating, removing ethanol, and drying until all ethanol volatilizes completely; adding 28ul of anhydrous enzyme water, mixing uniformly, eluting DNA from the magnetic beads, taking 1ug into terminal repair, and adding anhydrous enzyme to 25ul. Adding a terminal repair reagent to perform terminal repair under proper conditions.
Joint ligation and product purification
Universal adaptors at a concentration of 15uM were used and adaptor dilution work was performed based on the total amount of DNA entering the end repair. The following reagents were added to the linker ligation reaction:
Figure GDA0003695100950000041
after the reaction solution is briefly centrifuged, the reaction solution is incubated on a PCR instrument at 20 ℃ for 15 minutes, 9.5ul of Axygen beads are added to the reaction solution for resuspension, the supernatant is removed after magnetic separation, 200ul of 80% ethanol is added for cleaning, the reaction solution is incubated at room temperature for removing ethanol, and the reaction solution is dried and 20ul of enzyme-free water is added for eluting magnetic beads.
Library amplification
The purified product is subjected to PCR amplification by adopting a reaction system shown in the specification, so that the product meets the sequencing requirement.
Figure GDA0003695100950000051
The amplification conditions were: pre-denaturation at 98 ℃ for 45 seconds, denaturation at 98 ℃ for 15 seconds, annealing at 65 ℃ for 30 seconds, extension at 72 ℃ for 30 seconds, and circulation for 12 times; extension was carried out at 72℃for 1 minute.
According to the above-described method and idea for designing a probe, a probe was designed and synthesized for testing, and Biotin (Biotin) was present at the 5' end.
The DNA sample pool was mixed with hybridization buffer (10 mM Tris-HCl,2% bovine serum albumin, pH 8.0) (after mixing, the DNA sample pool concentration was not more than 50ng/ul at most), the reaction conditions were 95℃for 5 minutes, and then kept at 65 ℃. The reaction was performed in a PCR amplification instrument. Then in DNA sample library: the probe pool was added to the above mixture at a molar ratio of 1:100, and the reaction conditions were 65℃for 5 minutes. The hybridization reaction was placed in a PCR amplification apparatus and incubated at 65℃for 24 hours.
50ul of Dynabeads magnetic beads were mixed with 200ul of binding buffer (10 mM Tris-HCl,2% BSA) and the beads were separated by a magnetic separator and repeated 3 times; mixing the hybridization reaction product with streptavidin magnetic beads, separating in a magnetic separator, adding 500ul of washing buffer (containing 0.1% Tween-20 and 0.1% SDS) into the magnetic beads, incubating at 60 ℃ for 15min, and repeating for 3 times; the magnetic beads were mixed with 50ul of elution buffer (containing 10mM NaOH), incubated at 20℃for 15min, and the magnetic beads were separated by a magnetic separator, and a detection library was obtained from the supernatant.
The library is amplified by PCR by adopting a reaction system shown in the specification, so that the product reaches the sequencing requirement.
Figure GDA0003695100950000052
The amplification conditions were: pre-denaturation at 98 ℃ for 45 seconds, denaturation at 98 ℃ for 20 seconds, annealing at 65 ℃ for 30 seconds, extension at 72 ℃ for 25 seconds, and circulation for 5 times; extension is carried out at 72℃for 3 minutes.
Sequencing and analysis
Sequencing by using an Illumina HiSeq2000 next generation sequencing system, and carrying out data analysis to obtain gene mutation information. According to the method, the test results using different probes are as follows:
1. comparison of detection data of different probe lengths
The length of the probe has larger influence on the specificity and the middle target rate of detection, so 4 probes with different lengths are designed, the lengths of the probes are 80bp, 100bp, 120bp and 140bp respectively, NGS capture sequencing is carried out by using the probes, quality control is carried out on sequencing data, and the influence of different probe lengths on sequencing results is determined by the middle target rate, the coverage rate of a target area and the economy. The results of physical control are shown in the following table:
Figure GDA0003695100950000061
from the sequencing results, the target rate and the coverage rate of the target area in the 120bp probe are significantly higher than those of the 80bp probe and the 100bp probe. When the probe length is continuously increased to 140bp, the middle target rate and the coverage rate of the target area are not obviously improved, however, the increase of the probe length tends to cause the improvement of the probe synthesis cost, and the probe with the length of 120bp is comprehensively considered.
2. Comparison of different probe overlap lengths
The connection mode between adjacent probes is possibly related to the uniformity of probe coverage, so three connection modes, namely 10bp gap, 5bp overlap and 20bp overlap, are designed, NGS sequencing is carried out after capturing, and quality control results are as follows:
Figure GDA0003695100950000062
the coverage rate of 5bp overlap between adjacent probes is significantly increased compared with that of 10bp gap, and there is no significant difference from 20bp overlap.
3. Comparison of conventional coverage and optimized coverage patterns for intron regions
After the optimization, experiments are carried out by adopting probes shown as SEQ ID NO.1-197, and as most of gene fracture sites are positioned in an intron region of the gene, the high-frequency fracture interval of the MET gene intron is fully covered. Compared with the traditional coverage form (probes are designed on the area only close to the exons), the probe coverage situation of the introns of the coverage hot spot is shown in fig. 3, the upper diagram is the probe coverage situation designed by adopting the optimization technology of the patent, the lower diagram is the probe coverage situation after capturing by adopting the traditional probes, and the coverage of the optimized probe design on the introns is obviously superior to that of the traditional probe design. The number of intron region probes marked in FIG. 3 was increased by 25 over control 1, SEQ ID NOS.62-86, and the remaining parameter experiment groups were identical to control 1. If the breaking site of MET gene fusion is located in the hot spot intron region, the optimized probe is adopted to cover the breaking site, the sequencing depth is 1000X, the mutation abundance is 10%, and if the conventional probe is not adopted to cover the breaking site, the fusion omission is directly caused. Fig. 3 shows the experimental group in the upper half and the control group 1 in the lower half.
4. Comparison of conventional coverage and optimized coverage patterns of exons adjacent to introns
The coverage of intronic regions is extremely important for fusion gene detection, so we also designed specific probes for intronic regions adjacent to exons, and compared to conventional probe designs (probes are not designed in regions adjacent to introns) the coverage of intronic regions is shown in FIG. 4, where the upper panel is the optimized probe covering intronic regions adjacent to introns, and the lower panel is the conventional probe intron coverage. The number of probes in the exon adjacent to the intron region marked in FIG. 4 was increased by 1 compared with that in control group 2, SEQ ID NO.59, and the rest of the parameters were the same as those in control group 2. The capturing effect of the optimized probe intron region is obviously better than that of the traditional probe. Fig. 4 shows the experimental group in the upper half and the control group 1 in the lower half.
5. Verification of detection sensitivity
In the prior art, the problem of low detection sensitivity exists in the fusion gene detection, and the sensitivity is generally about 10% or more, so how to improve the detection sensitivity is a problem to be solved.
For PTPRZ1: exon8-MET: exon2 fusion mutation, mutant plasmids and wild plasmids are constructed, samples with different abundances are mixed according to the copy number proportion of the mutant in the wild, the probe library is adopted for capturing and sequencing to examine sensitivity, the probe of SEQ ID NO.198-199 is used as a control of the probe of SEQ ID NO.22, the detection sensitivity is examined, and each sample is repeatedly tested for 3 times, and the result is as follows:
Figure GDA0003695100950000071
as can be seen from the table, the detection probe library and the detection method provided by the invention can have better detection sensitivity to low-abundance samples, and can reach the detection sensitivity level of about 0.5%.
6. Verification of detection accuracy
The optimized probe library is adopted to perform MET gene fusion detection on 10 patient tumor tissue samples which are subjected to FISH and IHC detection and are subjected to MET fusion positive and 5 patient tumor tissue samples which are subjected to detection and negative respectively, and sequencing is performed through the optimized probe and the method, and the results show that the MET gene fusion can be better detected through the detection probe library and the detection method provided by the invention, and the detection results are the same as the detection results of FISH and IHC, so that the reliability of the method is proved, and meanwhile, fusion partner genes and specific fusion forms can be definitely detected through NGS.
Figure GDA0003695100950000081
Sequence listing
<110> Jiangsu province middle hospital
Nanjing Shihe gene Biotechnology Co.,Ltd.
<120> method for detecting MET fusion gene, kit and probe library
<130> none of
<160> 199
<170> SIPOSequenceListing 1.0
<210> 1
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
tagatcctat tacctttgag tgttcattta ctcttgtagg tgccaatttt tatagcgaaa 60
tacaaagtta tcccaacaca attactccta atagagttca ccgaggcccc aaaagctctt 120
<210> 2
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
ttttaaaaat catcataaga tttcaacatt caagaattaa acttttgttc tgttgtgctt 60
attcatcgct atttgcccag ttatttaatc agcctgcttc cggctatgga aaaaaaaaaa 120
<210> 3
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
aagaaaaaaa gaaatggaag tctcctcagg gttaaactcc tctgttgttc ttccttgcag 60
aaatttgagt tattatagta gaggataatc gttgcataat gaaatcattg ggacaattcg 120
<210> 4
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
tccatccact tctacctccg cctctaacaa tgaactcctt gtttctgcgg tgcccaaatc 60
tctctaaacc cgggtgggcg cggggcggtt agcggagacg tgggagaggc cgagagcaaa 120
<210> 5
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
gctcgcgccc ttcccggggt cagcgagcgg ggtgccagga gggtgcgcgc cctgcatctg 60
agcccggggt gacactcgcc tcccaagcgc caggaggggg agactcggtc ccgcttatct 120
<210> 6
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
ccggctgtgc taacttcaga ctgcctgagc tgggggagga gagcgcgcag ccagggcgag 60
aaaacttctc cacctagaaa gtttcacctt gtcgtgggcg gggcagaggc gggaggaaac 120
<210> 7
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
gcgacccccg cggggccagg cgcggcgcgg acggcaggaa gggcgggggc cgatttccct 60
ctgggtggtg ccagtcccca cctcagcggt cctcggaacc cgcggactag gggacggaca 120
<210> 8
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 8
gcgacccccg cggggccagg cgcggcgcgg acggcaggaa gggcgggggc cgatttccct 60
ctgggtggtg ccagtcccca cctcagcggt cctcggaacc cgcggactag gggacggaca 120
<210> 9
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 9
gctgagtcac tggcagggca gcgcgcgtgt gggaaggggc ggagggagtg cggccggcgg 60
gcgggcgggg cgctgggctc agcccggccg caggtgaccc ggaggccctc gccgcccgcg 120
<210> 10
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 10
gcgccccgag cgctttgtga gcagatgcgg agccgagtgg agggcgcgag ccagatgcgg 60
ggcgacagct gacttgctga gaggaggcgg ggaggcgcgg agcgcgcgtg tggtccttgc 120
<210> 11
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 11
gccgctgact tctccactgg ttcctgggca ccgaaaggta aaattgcagc ccctttcaga 60
tccagtaccc aatccctcgc ctcaggggtt ctgctttctt tgttccccta agagacctga 120
<210> 12
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 12
ctgctgttcc agggggcaaa accacgtagg tgggctagag tttaggggct tcggaaactg 60
aagagacgtg gccacggcga ggacgaaact agaatggggc ttgtcttttt agggggttgc 120
<210> 13
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 13
ttctgatggc cacctgtatg acttaggagg gagaggggcg ctgggacagt gggtgatgtg 60
tgactgttac ggcccagcaa gttttaaagc tgggatctga ctcagccctt acaaaaggga 120
<210> 14
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 14
tccggtcatc ctcgtcccac cgtgatgcag ctggcaaggt ttgagccgag ctgtttcctt 60
gttcccagcc ttgctttatc tgtgttatgt tggggtcctt ccaaggggca ggtgtttctg 120
<210> 15
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 15
tgaaagtctg aattcatttc tggcaatcac gcggggcttg tgatccatca attttccatc 60
gtaccttatc tctttctggg gcttgtggtg gacatctatc ttattaggtg aaatagatta 120
<210> 16
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 16
taaccagagg ctgagcgatg tggccagtcg tagtgctgac ccgataatta aagcaccagt 60
gaaagtactt tccctgacta ttgtcaatgc agaatttact ccgaagtacg gtttcccatt 120
<210> 17
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 17
catatctttc atgttttaaa agagccattt gctaatttgg cagttggaga gggctccaat 60
ggctcacgca tgaatagttg cccagtgtat tttaccttat cacagtttta tgttcaaagg 120
<210> 18
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 18
agccctcggg cagaatgaaa tattgtcaac tctcttaggc aaaataatca agatacttta 60
attgctatgt taagatggtc catgaatgtg agaggattgt aagaactgac gttggaggca 120
<210> 19
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 19
atatagacta tctggaccct ctcttgaatt ttaagaagac tgttcacatt ctgtagcttt 60
gggtgggggt ttattctgtc gctttcatca gccagacaca tgcacattgc catgcaaatg 120
<210> 20
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 20
ctatctggac cctctcttga attttaagaa gactgttcac attctgtagc tttgggtggg 60
ggtttattct gtcgctttca tcagccagac acatgcacat tgccatgcaa atggattcag 120
<210> 21
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 21
cttcatttct gacaactgaa ctgctctcgc cttgaacctg ttttggcaga taaacctctc 60
ataatgaagg cccccgctgt gcttgcacct ggcatcctcg tgctcctgtt taccttggtg 120
<210> 22
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 22
cagaggagca atggggagtg taaagaggca ctagcaaagt ccgagatgaa tgtgaatatg 60
aagtatcagc ttcccaactt caccgcggaa acacccatcc agaatgtcat tctacatgag 120
<210> 23
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 23
catcacattt tccttggtgc cactaactac atttatgttt taaatgagga agaccttcag 60
aaggttgctg agtacaagac tgggcctgtg ctggaacacc cagattgttt cccatgtcag 120
<210> 24
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 24
gactgcagca gcaaagccaa tttatcagga ggtgtttgga aagataacat caacatggct 60
ctagttgtcg acacctacta tgatgatcaa ctcattagct gtggcagcgt caacagaggg 120
<210> 25
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 25
acctgccagc gacatgtctt tccccacaat catactgctg acatacagtc ggaggttcac 60
tgcatattct ccccacagat agaagagccc agccagtgtc ctgactgtgt ggtgagcgcc 120
<210> 26
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 26
ctgggagcca aagtcctttc atctgtaaag gaccggttca tcaacttctt tgtaggcaat 60
accataaatt cttcttattt cccagatcat ccattgcatt cgatatcagt gagaaggcta 120
<210> 27
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 27
aaggaaacga aagatggttt tatgtttttg acggaccagt cctacattga tgttttacct 60
gagttcagag attcttaccc cattaagtat gtccatgcct ttgaaagcaa caattttatt 120
<210> 28
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 28
tacttcttga cggtccaaag ggaaactcta gatgctcaga cttttcacac aagaataatc 60
aggttctgtt ccataaactc tggattgcat tcctacatgg aaatgcctct ggagtgtatt 120
<210> 29
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 29
ctcacagaaa agagaaaaaa gagatccaca aagaaggaag tgtttaatat acttcaggct 60
gcgtatgtca gcaagcctgg ggcccagctt gctagacaaa taggagccag cctgaatgat 120
<210> 30
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 30
gacattcttt tcggggtgtt cgcacaaagc aagccagatt ctgccgaacc aatggatcga 60
tctgccatgt gtgcattccc tatcaaatat gtcaacgact tcttcaacaa gatcgtcaac 120
<210> 31
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 31
cgtcaacaaa aacaatgtga gatgtctcca gcatttttac ggacccaatc atgagcactg 60
ctttaatagg gtaagtcaca tcagttcccc acttataaac tgtgaggtat aaattagaaa 120
<210> 32
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 32
ttgttcatgt ctggattcac attaactcta tgaccatatt ttattccaga cacttctgag 60
aaattcatca ggctgtgaag cgcgccgtga tgaatatcga acagagttta ccacagcttt 120
<210> 33
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 33
gcagcgcgtt gacttattca tgggtcaatt cagcgaagtc ctcttaacat ctatatccac 60
cttcattaaa ggagacctca ccatagctaa tcttgggaca tcagagggtc gcttcatgca 120
<210> 34
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 34
tatatccacc ttcattaaag gagacctcac catagctaat cttgggacat cagagggtcg 60
cttcatgcag gtaagtgctt tctgagagta gctgtgtctg ttctatctgg tattgtgcaa 120
<210> 35
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 35
taaactgagc ttgttggaat aaggatgtta taactttttt gctgtttagg ttgtggtttc 60
tcgatcagga ccatcaaccc ctcatgtgaa ttttctcctg gactcccatc cagtgtctcc 120
<210> 36
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 36
gtctccagaa gtgattgtgg agcatacatt aaaccaaaat ggctacacac tggttatcac 60
tgggaagaag gtaagctgtt cccacaggga atttccatag acgtggtttt tcccaaatgc 120
<210> 37
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 37
acaaactaga tacccctctg gaagctcttt ccaccccttc tcttcacaga tcacgaagat 60
cccattgaat ggcttgggct gcagacattt ccagtcctgc agtcaatgcc tctctgcccc 120
<210> 38
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 38
accctttgtt cagtgtggct ggtgccacga caaatgtgtg cgatcggagg aatgcctgag 60
cgggacatgg actcaacaga tctgtctgcc tgcaatctac aaggtaggaa tctctaacag 120
<210> 39
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 39
atgtgtgcga tcggaggaat gcctgagcgg gacatggact caacagatct gtctgcctgc 60
aatctacaag gtaggaatct ctaacagctg gcatacatgt ttttgtttgg tgtttttttt 120
<210> 40
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 40
aaattataat atattgggtt tttttaaaag ttctatgttg tccttgtagg ttttcccaaa 60
tagtgcaccc cttgaaggag ggacaaggct gaccatatgt ggctgggact ttggatttcg 120
<210> 41
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 41
gaggaataat aaatttgatt taaagaaaac tagagttctc cttggaaatg agagctgcac 60
cttgacttta agtgagagca cgatgaatac gtaaggatct taaaatgctt tgctggggtg 120
<210> 42
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 42
taaagaaaac tagagttctc cttggaaatg agagctgcac cttgacttta agtgagagca 60
cgatgaatac gtaaggatct taaaatgctt tgctggggtg tgcttggaaa ataggttttg 120
<210> 43
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 43
gaaaattcct tggatttgtc atgtattaaa ctttgggttt tttttccaga ttgaaatgca 60
cagttggtcc tgccatgaat aagcatttca atatgtccat aattatttca aatggccacg 120
<210> 44
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 44
ggacaacaca atacagtaca ttctcctatg tggtaaggaa gattctatcc tatcatgttt 60
gatttttact taatctattt aaattataag atgaacaagt tactttgttt tgtttttatc 120
<210> 45
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 45
tcccctccag gatcctgtaa taacaagtat ttcgccgaaa tacggtccta tggctggtgg 60
cactttactt actttaactg gaaattacct aaacagtggg aattctagac acatttcaat 120
<210> 46
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 46
ctggaaatta cctaaacagt gggaattcta gacacatttc aattggtgga aaaacatgta 60
ctttaaaaag gtgttgtaaa tttatttttt gttgcatctg tcaatttgaa ttaatatctg 120
<210> 47
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 47
tgtgtatctc taatagctaa aattcacttc cttaattttt tttgttcagt gtgtcaaaca 60
gtattcttga atgttatacc ccagcccaaa ccatttcaac tgagtttgct gttaaattga 120
<210> 48
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 48
aaattgactt agccaaccga gagacaagca tcttcagtta ccgtgaagat cccattgtct 60
atgaaattca tccaaccaaa tcttttatta ggtaagtaga agcttctgat gggtataaga 120
<210> 49
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 49
agacaagcat cttcagttac cgtgaagatc ccattgtcta tgaaattcat ccaaccaaat 60
cttttattag gtaagtagaa gcttctgatg ggtataagaa aacaatgaat acaaggatga 120
<210> 50
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 50
ggtggaaaga acctctcaac attgtcagtt ttctattttg ctttgccagt ggtgggagca 60
caataacagg tgttgggaaa aacctgaatt cagttagtgt cccgagaatg gtcataaatg 120
<210> 51
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 51
aaacctgaat tcagttagtg tcccgagaat ggtcataaat gtgcatgaag caggaaggaa 60
ctttacagtg gtaagtcctt tgagcaatgg ttctactcag agctctgcat ctttgcctct 120
<210> 52
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 52
gttgccaagc tgtattctgt ttacagtgga taattgtgtc tttctctagg catgtcaaca 60
tcgctctaat tcagagataa tctgttgtac cactccttcc ctgcaacagc tgaatctgca 120
<210> 53
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 53
actccccctg aaaaccaaag cctttttcat gttagatggg atcctttcca aatactttga 60
tctcatttat gtacataatc ctgtgtttaa gccttttgaa aagccagtga tgatctcaat 120
<210> 54
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 54
tcctgtgttt aagccttttg aaaagccagt gatgatctca atgggcaatg aaaatgtact 60
ggaaattaag gtaagaaatg ctttaaacac tgtcttaaat catcagctca aacttaattg 120
<210> 55
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 55
tgcagaactg tgaagtgtta acaacctttt tttttttttt tcctttcagg gaaatgatat 60
tgaccctgaa gcagttaaag gtgaagtgtt aaaagttgga aataagagct gtgagaatat 120
<210> 56
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 56
acacttacat tctgaagccg ttttatgcac ggtccccaat gacctgctga aattgaacag 60
cgagctaaat atagaggtgg gattcctgca ttcctctcat gatgtaaata aggaagccag 120
<210> 57
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 57
acattctgaa gccgttttat gcacggtccc caatgacctg ctgaaattga acagcgagct 60
aaatatagag gtgggattcc tgcattcctc tcatgatgta aataaggaag ccagtgtaat 120
<210> 58
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 58
aatatctatc atggctaaat gctgactttt ctttatttgt catttttagt ggaagcaagc 60
aatttcttca accgtccttg gaaaagtaat agttcaacca gatcagaatt tcacaggatt 120
<210> 59
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 59
gattgctggt gttgtctcaa tatcaacagc actgttatta ctacttgggt ttttcctgtg 60
gctgaaaaag agaaagcaaa ttaaaggtgc atttttgtta ctgttcattt ttagaagtta 120
<210> 60
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 60
ccttaagaac acagtcatta cagtttaaga ttgtcgtcga ttcttgtgtg ctgtcttata 60
tgtagtccat aaaacccatg agttctgggc actgggtcaa agtctcctgg ggcccatgat 120
<210> 61
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 61
agccgtcttt aacaagctct ttctttctct ctgttttaag atctgggcag tgaattagtt 60
cgctacgatg caagagtaca cactcctcat ttggataggc ttgtaagtgc ccgaagtgta 120
<210> 62
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 62
agcccaacta cagaaatggt ttcaaatgaa tctgtagact accgagctac ttttccagaa 60
ggtatatttc agtttattgt tctgagaaat acctatacat atacctcagt gggttgtgac 120
<210> 63
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 63
attgttgttt atttttggtt ttgcatttat atttttataa aaacctaaag gaagtattta 60
cctctgccaa gtaagtattt gacacaaaat tacatggctc ttaattttaa aagaacccat 120
<210> 64
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 64
gtatatatta cattatgatt ttagagtcca taagctctca tttcacaaaa aggttaattt 60
gagcaaaagt aatttgttta tcatctaagt gcaatagtaa gaaattgcga agctctcttt 120
<210> 65
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 65
tacaatccag gaagagttaa gttacaaaat atacttattt aaatgtaagt tggaactgct 60
acatttttta cctgttgaag cccaaacatt gaaattatac tgttagtaat tcttcgaagt 120
<210> 66
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 66
gttttcaatg aactgttagt acacagcctt tttcccacca tattctagga cttgaatgta 60
ttttgagact tagccaagga aaaccttcaa ttatgccatg aaaaaaagga ggggtcaata 120
<210> 67
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 67
tcatcagctt tgtaaaacac tatgcctagt aatgttcagg ttaatcagag ttttcatgtt 60
gttttattta aatctcctgg taaaagcaaa aggtctgtat tgtatcagct ccattatctt 120
<210> 68
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 68
tagaagttac aggatgtgag tcaagtacaa gcatttcctt ggttgaatat ttaccattgg 60
acaaataaaa tgagtcacag atcattgagg atactggaaa agttagaagt tgctcatcca 120
<210> 69
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 69
aacaagttca agagcaatga agcacttaac attttaacat tttcaacact tactacctct 60
tatgttttga agtttatgtt atttctatgg agatacacat agtaaacatt gtctttgccc 120
<210> 70
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 70
tgattccatt cacctttaaa aatccattcg tttaaccgtg tggaaaaatc aaacctagtt 60
tattgttttg aaatttagat ctatttagta ttttatgtgc acatttagtg catctattta 120
<210> 71
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 71
gtattttata tgcacatttc atagttctaa tctgagatca ttaaaattta caaattttct 60
ttgaaaaaaa aacttaccta atcttctttg aacctcctta ctcaccaaag ctctgtcatc 120
<210> 72
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 72
attgctaaga aggttgagtt tcacactctt ttctccattg agcctgctcc ttggagacat 60
gaaaagaaaa caggtaaaag agggtcattt agagagaatg agaaaatagg tgcacagcca 120
<210> 73
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 73
aaacctaatg aagaggcaac tgcagagctt tcctctctac atctggtggg gacagcattc 60
tcatcagact ttttcacgga gacctagagt gctatgtggt gtgacatcag ggtggcacac 120
<210> 74
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 74
tgatggtttc aattggtttc tgcacatgtt ggaatttagc tgaagagtca cgttttcatg 60
ccaaagggct tttatccatg tctcaccaag gatttccctc aatctgtgca cccttaagca 120
<210> 75
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 75
tttagagccc tgatctccag atgcaaaggc tttaggaagt gagaatgaaa gacctgagtt 60
tagagaggct gattggcatt cccaatcccc tggggaaggt ttagagaccc tgactccttg 120
<210> 76
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 76
gaattaaggg agcaagtacc cagctaggct ccttccttcc tcactcaccc aacatttcag 60
gtacttcact gatgttccac atccttcttt aaaggttgct cttgtctttt ttctggctag 120
<210> 77
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 77
tgtctactat aactgtaatt gatgcccaac gcttttctgg aaccactttt ggccaagttc 60
atttattatt aatcaaactg tccactgtag aaaatactaa aaatgctcaa gtgggattag 120
<210> 78
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 78
gaatagtcaa ggtactaaca gcattctttt tatgcccttc tctcagattc tgattctcct 60
gcttatttgc aaacaaatga tacattttgg tgctaatgag gaacccccac ataaccttct 120
<210> 79
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 79
ccctgtgtta catactaata catttcaata ctatgcctag tttatcttca tgtcagttgc 60
tgtggctatg atgccccctc cttgatatgt gtgaattccc agtggaaaga gaaagggaaa 120
<210> 80
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 80
gtggaaatgc cctatttggc attaagaaat tgactatcag caccatttct tcccctgaaa 60
taaaaaaaaa aattctcctt gcaaaaggga actttgcctg aggttcttac agagctttgg 120
<210> 81
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 81
ttataaagat caacttataa agaatgctta cccctttcat agtgtcctta actaaacaac 60
aaggatggtc cactaaccga gatctaacct gccttctcta aacaacagta acactaaatc 120
<210> 82
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 82
cagtgccatc actgcacagt ggagaattta ccactaatgt gaaaagcttt cagttttggg 60
aatatagcca ttatttattt ctaatcatat gtgtattttt cccttggcca ggaatccata 120
<210> 83
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 83
ggttttgcac aatagtaatt aattccatta acaaatagta gtgtctcaaa aggcatcttt 60
ttcattttct tatatttgag ctggattttt gtgagacgag gcaattgctc aactaccttt 120
<210> 84
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 84
gctgctacca ctgcttccat tcttaaggac atagtatatt caaaaataaa ccataagcat 60
ggctttttgc tattgataaa gagagaaatg tctaaggaaa tgagggtaaa aagctttcaa 120
<210> 85
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 85
aattaatact tagtctactt aaatgaaaat ctgtaaacat ctaatgaaat gcttgtatat 60
ataacttagt atcttttccc aatttattat catttttatc aaactaattc cattataaaa 120
<210> 86
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 86
gctcttcctg tttcagtccc cattaaatga ggttttactg ttgttcttta ataattttcc 60
ttcatcttac agatcagttt cctaattcat ctcagaacgg ttcatgccga caagtgcagt 120
<210> 87
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 87
atcctctgac agacatgtcc cccatcctaa ctagtgggga ctctgatata tccagtccat 60
tactgcaaaa tactgtccac attgacctca gtgctctaaa tccagagctg gtccaggcag 120
<210> 88
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 88
tgcagcatgt agtgattggg cccagtagcc tgattgtgca tttcaatgaa gtcataggaa 60
gaggtaagta tttccactca gctttttgtt aaatacgatt ttccagtaag cattttatct 120
<210> 89
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 89
ttggcctttg cagattagga acttagacaa tggtgaaagc aactgacaga gcagtgataa 60
caagtgtact tgatttctgt tctatagaaa tgtagccctg taaatcatat ccgtggggat 120
<210> 90
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 90
ttgcccttgt gcatggaagc aattggataa tcccccaaat atattagaac taaatcacaa 60
ttcgtcctcg tcctgtgtgt actagcaatt atagtttctt caaaggtgcc atttactttc 120
<210> 91
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 91
ttctaaaact cagggccagg cgcagtggct cacacgtgta atcccagcac tttgggaggc 60
cgaggcaggt ggatcacctg aggtcaggag ttcaaaacca tcctggccaa catggcaaaa 120
<210> 92
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 92
ccccgtctct actaaaaaaa tacaaaaatt agccaggcgt ggtggcgggt gcctttaatc 60
ccaactactg gggaggctga agcaaggaga attgcttgaa cccaggaggt ggaagttgca 120
<210> 93
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 93
gtgagccaag gttgtgccac agcactccag cctgggcagc agagcgagac tccatgtcaa 60
aaaaataaat acttataaat aaataaatat cactccttta attttgagta tttttattca 120
<210> 94
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 94
atctctctcc agtctttctt taccctgaga acagtgacaa actctatgaa gcctggttta 60
tagcagtttg tacactgctg gacagcatca gaagacagag aatttatagc attctcctga 120
<210> 95
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 95
tctaaagcaa catatatcat ctctacaatg cactccaatt tctttataca aagataaatg 60
aatatttgta ataagctagc caaagcagca ataacagcta gcataaacag tatttgtgga 120
<210> 96
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 96
aatatttagc aggaaaagaa accaatcaaa aaccgggaaa tgaacttcat tcttcttgtt 60
gttttttttt ttctaaaaag cttttaccct taatactaaa tggcctctga tcccttttat 120
<210> 97
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 97
tctatatgtg ctgcaagagg ttgtacaggc atctgccagt gtgatacaag agaagctgat 60
ggcgtgattt cccttatatg aacacaaggc cttctcactt tcctgtggta gcatccacac 120
<210> 98
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 98
attcttctgt caaacacccc agagcgtaat cctttgtgtg ctccttcttc cccaagagtg 60
gcttcactgt taacaaacat ctttccattt ctcttcagag taatatatag ttctgtcata 120
<210> 99
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 99
ggcctataaa tcccagtaat tgcatcaatt ttagagtgtg tggactcact aattgtgttc 60
taattctaca catttggaaa actagaattt tttatcatga aaggtactaa aatggcaatt 120
<210> 100
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 100
atttctcttt tgaagttata atcattaaca gctctataaa tattagctac tatgtattta 60
tatgtttttc tgcaggagaa taggagcact caaaagcata agttttattt tattcttctt 120
<210> 101
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 101
tgcattagta gagggcagcc taatgcctga cactcacata ctaggcactc atggtgtctt 60
ggccagctgg atgaattaat tagtgaatga cttacacagc tatcagacat ttggcacctc 120
<210> 102
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 102
tgggggaaat tactgccact ggataaaagg ctaccattgg gaaaatgatg tggttaaagc 60
cagagagaac tggatgaagt gagtcagggt gaatttgctt catctgggca actgcctttc 120
<210> 103
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 103
agtttctgcc aacctggatt acgtattaac cagtgactaa tggggaaatc cttattctat 60
aatactaatc ctatttttaa tggtaacatt tttatttcat ttcagcttat tagaatatag 120
<210> 104
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 104
agaacttatt ttattatagt tcttcatgtg ggttaacttt attttcatat tttaaaatac 60
tatgtcatcc tttaaaaaaa tttatttgat gaggccgatg ttactcacct tttcagtggt 120
<210> 105
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 105
aaaaaaattt atttgatgag gccgatgtta ctcacctttt cagtggttcc actgtggttg 60
aatattttat taggttaggc tttaatatga gtcatatcat ctacaactta ttcatgaatt 120
<210> 106
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 106
tcataattaa atgttacgca gtgctaacca agttctttct tttgcacagg gcattttggt 60
tgtgtatatc atgggacttt gttggacaat gatggcaaga aaattcactg tgctgtgaaa 120
<210> 107
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 107
tgtgtatatc atgggacttt gttggacaat gatggcaaga aaattcactg tgctgtgaaa 60
tccttgaaca gtaagtggca ttttatttaa ccatggagta tacttttgtg gtttgcaacc 120
<210> 108
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 108
attcactgtt ccataatgaa gttaatgtct ccaccactgg atttctcagg aatcactgac 60
ataggagaag tttcccaatt tctgaccgag ggaatcatca tgaaagattt tagtcatccc 120
<210> 109
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 109
aatgtcctct cgctcctggg aatctgcctg cgaagtgaag ggtctccgct ggtggtccta 60
ccatacatga aacatggaga tcttcgaaat ttcattcgaa atgagactca tgtaagttga 120
<210> 110
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 110
gtctccgctg gtggtcctac catacatgaa acatggagat cttcgaaatt tcattcgaaa 60
tgagactcat gtaagttgac tgccaagctt actaactggc aaactagctg taagccagcc 120
<210> 111
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 111
agaacagtag atgcttagtt tatgcttttc taactctctt tgactgcaga atccaactgt 60
aaaagatctt attggctttg gtcttcaagt agccaaaggc atgaaatatc ttgcaagcaa 120
<210> 112
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 112
tagccaaagg catgaaatat cttgcaagca aaaagtttgt ccacagagac ttggctgcaa 60
gaaactgtat gtaagtatca gaatctctgt gccacaatcc aaattaagtg acaaggagga 120
<210> 113
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 113
taaattattc tatttcagcc acgggtaata atttttgtcc tttctgtagg ctggatgaaa 60
aattcacagt caaggttgct gattttggtc ttgccagaga catgtatgat aaagaatact 120
<210> 114
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 114
atagtgtaca caacaaaaca ggtgcaaagc tgccagtgaa gtggatggct ttggaaagtc 60
tgcaaactca aaagtttacc accaagtcag atgtggtaat gtattggtta tctctgagtt 120
<210> 115
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 115
aaagctgcca gtgaagtgga tggctttgga aagtctgcaa actcaaaagt ttaccaccaa 60
gtcagatgtg gtaatgtatt ggttatctct gagtttctcc tcttttactt tcatatccaa 120
<210> 116
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 116
tgtatggtca catctctcac ctcatctgtc ctgtttcttg ttttactagt ggtcctttgg 60
cgtgctcctc tgggagctga tgacaagagg agccccacct tatcctgacg taaacacctt 120
<210> 117
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 117
tgatataact gtttacttgt tgcaagggag aagactccta caacccgaat actgcccaga 60
ccccttgtaa gtagtctttc tgtacctctt acgttcttta cttttacaga aatgcctgcc 120
<210> 118
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 118
ttcaaagggt ctcttacagc atgtctttct ttttggaaca gatatgaagt aatgctaaaa 60
tgctggcacc ctaaagccga aatgcgccca tccttttctg aactggtgtc ccggatatca 120
<210> 119
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 119
gcgatcttct ctactttcat tggggagcac tatgtccatg tgaacgctac ttatgtgaac 60
gtaaaatgtg tcgctccgta tccttctctg ttgtcatcag aagataacgc tgatgatgag 120
<210> 120
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 120
gtggacacac gaccagcctc cttctgggag acatcatagt gctagtacta tgtcaaagca 60
acagtccaca ctttgtccaa tggttttttc actgcctgac ctttaaaagg ccatcgatat 120
<210> 121
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 121
tctttgctct tgccaaaatt gcactattat aggacttgta ttgttattta aattactgga 60
ttctaaggaa tttcttatct gacagagcat cagaaccaga ggcttggtcc cacaggccac 120
<210> 122
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 122
ggaccaatgg cctgcagccg tgacaacact cctgtcatat tggagtccaa aacttgaatt 60
ctgggttgaa ttttttaaaa atcaggtacc acttgatttc atatgggaaa ttgaagcagg 120
<210> 123
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 123
aaatattgag ggcttcttga tcacagaaaa ctcagaagag atagtaatgc tcaggacagg 60
agcggcagcc ccagaacagg ccactcattt agaattctag tgtttcaaaa cacttttgtg 120
<210> 124
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 124
tgttgtatgg tcaataacat ttttcattac tgatggtgtc attcacccat taggtaaaca 60
ttccctttta aatgtttgtt tgttttttga gacaggatct cactctgttg ccagggctgt 120
<210> 125
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 125
agtgcagtgg tgtgatcata gctcactgca acctccacct cccaggctca agcctcccga 60
atagctggga ctacaggcgc acaccaccat ccccggctaa tttttgtatt ttttgtagag 120
<210> 126
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 126
acggggtttt gccatgttgc caaggctggt ttcaaactcc tggactcaag aaatccaccc 60
acctcagcct cccaaagtgc taggattaca ggcatgagcc actgcgccca gcccttataa 120
<210> 127
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 127
atttttgtat agacattcct ttggttggaa gaatatttat aggcaataca gtcaaagttt 60
caaaatagca tcacacaaaa catgtttata aatgaacagg atgtaatgta catagatgac 120
<210> 128
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 128
attaagaaaa tttgtatgaa ataatttagt catcatgaaa tatttagttg tcatataaaa 60
acccactgtt tgagaatgat gctactctga tctaatgaat gtgaacatgt agatgttttg 120
<210> 129
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 129
tgtgtatttt tttaaatgaa aactcaaaat aagacaagta atttgttgat aaatattttt 60
aaagataact cagcatgttt gtaaagcagg atacatttta ctaaaaggtt cattggttcc 120
<210> 130
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 130
aatcacagct cataggtaga gcaaagaaag ggtggatgga ttgaaaagat tagcctctgt 60
ctcggtggca ggttcccacc tcgcaagcaa ttggaaacaa aacttttggg gagttttatt 120
<210> 131
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 131
ttgcattagg gtgtgtttta tgttaagcaa aacatacttt agaaacaaat gaaaaaggca 60
attgaaaatc ccagctattt cacctagatg gaatagccac cctgagcaga actttgtgat 120
<210> 132
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 132
gcttcattct gtggaatttt gtgcttgcta ctgtatagtg catgtggtgt aggttactct 60
aactggtttt gtcgacgtaa acatttaaag tgttatattt tttataaaaa tgtttatttt 120
<210> 133
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 133
taatgatatg agaaaaattt tgttaggcca caaaaacact gcactgtgaa cattttagaa 60
aaggtatgtc agactgggat taatgacagc atgattttca atgactgtaa attgcgataa 120
<210> 134
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 134
ggaaatgtac tgattgccaa tacaccccac cctcattaca tcatcaggac ttgaagccaa 60
gggttaaccc agcaagctac aaagagggtg tgtcacactg aaactcaata gttgagtttg 120
<210> 135
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 135
gctgttgttg caggaaaatg attataacta aaagctctct gatagtgcag agacttacca 60
gaagacacaa ggaattgtac tgaagagcta ttacaatcca aatattgccg tttcataaat 120
<210> 136
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 136
gtaataagta atactaattc acagagtatt gtaaatggtg gatgacaaaa gaaaatctgc 60
tctgtggaaa gaaagaactg tctctaccag ggtcaagagc atgaacgcat caatagaaag 120
<210> 137
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 137
aactcgggga aacatcccat caacaggact acacacttgt atatacattc ttgagaacac 60
tgcaatgtga aaatcacgtt tgctatttat aaacttgtcc ttagattaat gtgtctggac 120
<210> 138
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 138
agattgtggg agtaagtgat tcttctaaga attagatact tgtcactgcc tatacctgca 60
gctgaactga atggtacttc gtatgttaat agttgttctg ataaatcatg caattaaagt 120
<210> 139
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 139
tggtacttcg tatgttaata gttgttctga taaatcatgc aattaaagta aagtgatgca 60
acatcttgta tactgatagt ggttattgcc agtcatgctt gattacctgc atttgcataa 120
<210> 140
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 140
ccagcggagc ggtcctgcgc ccccgccccc tccaggagcc gcggcgcgca cagccgggct 60
ggagcgcgca cccggcactg aggcttcgct gctctcggag cgctcagacc gcggccgccg 120
<210> 141
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 141
cagccggcga aagaggcaaa gtcccgcacg ccggaggaca tgcgcctcgg ctagcggccc 60
cgggccccac caccgtgcgg ctttctccag attattcctc tctcgctgtc tctgactgtc 120
<210> 142
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 142
tctctctgtc tctgtctctg tctctctctc tctcacacac acacacacac acacaaacac 60
acatacgcac gcacgatctc acttcgatct atacactgga ggattaaaac aaacaaacaa 120
<210> 143
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 143
aaaaaacatt tccttcgctc cccctccctc tccactctga gaagcagagg agccgcacgg 60
cgaggggccg cagaccgtct ggaaatgcga atcctaaagc gtttcctcgc ttgcattcag 120
<210> 144
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 144
ctcctctgtg tttgccgcct gggtgagtga gaagagctcg gtggggtttc agctccggga 60
tcggtgggat gagggtggga gcatttcagc gtgtccgcga cttgccgccg ccgccgccat 120
<210> 145
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 145
ctagccagga ggaaaaaggg acagccaact gggctcccac ggagcgggcg gccgcgcggt 60
gcaggcagct gcgtgggatt tgcgcgcccc ctccccgccc cgcgccctcg ccccttccat 120
<210> 146
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 146
cggcccgcgg gcattcgtgc cccgggcccc aggagacgga gctactggag acggagggct 60
actcggatcc ctgccgccac cgttcttctc tcctcttttg caaagtgtag aaatcgcctt 120
<210> 147
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 147
ttagatatac ataggaagat aaatgaccag aaatacagct gtggtgcggg gctgtgtact 60
gtactgtctt ttttgctgtt catttttatg ctataggtat gatgggctta aatggaaagt 120
<210> 148
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 148
acacgtgtct ggtgtgaatt gcagacacac acacacacac acacacacac ctgaaaggta 60
gtaacaggca caagcaccaa cctgactttt cagggttttt tttattactt tcaatttagt 120
<210> 149
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 149
catattcaag tctgcgcaat tacttacaaa aaaaaaagtt ccatctaaat ctctaggttt 60
ggtcagtgct gccaaagtca gaggagagct gcaggttgat atacttattc acagatttca 120
<210> 150
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 150
tttttcatct gcaccctcca ggttacattt aaaactgaaa ttgcattcag caatagccag 60
tttaagcatt ccctttacct gcgatgcaga ctcaagtttt ccagtcattt tcgagaagtg 120
<210> 151
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 151
caagattgga cttttgcgtt ttattaaaga aatgcttttt ttccttcatg attttccatc 60
gcgatagaat ataatgggtt tacgcattaa cctgaaagtt acaaagtgtt gtacttcgct 120
<210> 152
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 152
cttcgctttg tgagtacaca tatttaattc ttttcagagg ctcccaattt ttcaatttta 60
gatggttcat agtagagtag atattaagcg tacattttca tccaatagat ggtgctgctc 120
<210> 153
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 153
ggacatatat ttttctacat actgattact tggtttttct tttttataga ttgggctaat 60
ggatactaca gacaacagag aaaacttgtt gaagagattg gctggtccta tacaggtaaa 120
<210> 154
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 154
catattactt atataatgag atttagcaga aacttttatt gttttgtatc tatttttata 60
tataaaagga agctttgtag cacaacacat catgtcaact tagctaaatg gatagttaga 120
<210> 155
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 155
ttaattaata gatatataaa atataaaacg atatcttatg ggctttccat aaacaaattt 60
ggtaatgtag ggcttattga catccaccca aactgtattt gaagctcagg cccaagctgt 120
<210> 156
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 156
ctatatacct tcaagaaata acataacctg gggctctgtt tttttcaacg gtgaaatggg 60
gggctgttct gagcattaaa tgagataaat aaagtgtgaa gcacttgtca cagagcctgc 120
<210> 157
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 157
ttctaaacag aaagctctca acaaatgtta gctgctggag ttgttatgat catgctaatg 60
attatttttg ttcatttaac aaatattgat gggattcttg ctctcagaag gggcattctt 120
<210> 158
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 158
ctgaattact gttgttaatt tattggtgtt agagtaaaaa atgattttgt cacattacta 60
gactttgcct agaacattat gaacatctga agttggcttg aaatagttac aaccaaaaat 120
<210> 159
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 159
catcagcaga aactctggga gagaaagttc tagccctgag tggaagaata tgagtggaat 60
ttgggtgaac catgacatgc ctagtaacca tgtgggatgg agttgagcat tagagttggg 120
<210> 160
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 160
tactcattag cagtaaactt gggttgataa gataaagtca gattacaagg gctttaccat 60
gagcctggcc aattttactt aatagatgaa gtgcagaagc atgctgaatt ttgtagataa 120
<210> 161
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 161
ggatgtattt tctttcttct ttttaattgc tattttaaaa gtagtaaata ttcattgtag 60
aaaatttaga aataggttca agtacaaaga aaaacataaa atcattattt tatttccctc 120
<210> 162
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 162
aagaaaaaca taaaatcatt attttatttc cctcaggaat agccacttaa aaaactgcta 60
tagtcctttt agacagtttt tattatccaa aatttatata ttttatttat agagttatgc 120
<210> 163
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 163
ttgcatggta atttaagaaa ctaaatttct tactccttct tttccctagg agcactgaat 60
caaaaaaatt ggggaaagaa atatccaaca tgtaatagcc caaaacaatc tcctatcaat 120
<210> 164
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 164
attgatgaag atcttacaca agtaaatgtg aatcttaaga aacttaaatt tcagggttgg 60
gataaaacat cattggaaaa cacattcatt cataacactg ggaaaacagg taaaatattt 120
<210> 165
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 165
gcattctgtt tgcctttaat atatttttca gacctggagt atgtttagac tagtttcatc 60
tcattttcct ttgaatagtg tactatgaac tagatagaag ttacatgtag aagaaaccaa 120
<210> 166
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 166
atggagcaga gaaaatggga aatttagaca atattttgac aatttgtaca aaaaaaaaat 60
gaccaatgtc atcatgtcat gttttcctac aaggtaacaa taatgatgct gcctctagaa 120
<210> 167
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 167
gatgtgataa tgtgatttac agctaatata atttagtcaa ttacttagtc aatcaggatt 60
tctttttctt gagcattata gtttgatctt ttctgcctag cctcatgtta tagtcagtat 120
<210> 168
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 168
ttggatatga aaaaagcaat tggctataat tgaaatttaa gaaaataaat tcctagctct 60
tctatataga aggtttaaag ttgtatccca tccttaggaa accctctcta agtgtctttt 120
<210> 169
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 169
tattgagcct atcttttttt ttttttaaaa aaaagcaaaa tataatacat taaaatttaa 60
gtacaaattc taataagcta tacatagata aataatttcc aaaaagtgac accttttctt 120
<210> 170
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 170
ttttgatatt ctagtttttt taaaaattgt attttgggaa attatgtaaa ggcaaatata 60
cacgtaagac aaagattaga aaaatattca aaattataat agtagctcta tggggataag 120
<210> 171
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 171
ctttatcatt ggtgaatttt ttttatattt tctatattta ggtaatgtaa ttatttgaac 60
ataataattt aatttcaaaa ctcaagagag tagtagtcag gcactgtggc tcacgcctgt 120
<210> 172
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 172
gatcccagca cttcgggagg ccgaagtggc tggatcactt gaggtcaaga gtaccagact 60
agcctggcca atatggcaaa aacccatctc tactaaaaat acaaaaatta gctgggtgtg 120
<210> 173
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 173
aacccatctc tactaaaaat acaaaaatta gctgggtgtg gtggcacact cctgtaattc 60
cagatactca ggaggctgag acacaagaat cacttgaact caagagttgg aggctgcagt 120
<210> 174
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 174
aaaattttga ttttcagaag cttaggtgca attgtatttc tttttttagt ggaaattaat 60
ctcactaatg actaccgtgt cagcggagga gtttcagaaa tggtgtttaa agcaagcaag 120
<210> 175
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 175
ataacttttc actggggaaa atgcaatatg tcatctgatg gatcagagca tagtttagaa 60
ggacaaaaat ttccacttga ggtaagtcag gagatctgct gtgtactatt ttattttcta 120
<210> 176
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 176
ctggggaaaa tgcaatatgt catctgatgg atcagagcat agtttagaag gacaaaaatt 60
tccacttgag gtaagtcagg agatctgctg tgtactattt tattttctaa ataattgatg 120
<210> 177
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 177
ttttatgaag tctttgtgta tcataaaact atcattgtta cttttataga tgcaaatcta 60
ctgctttgat gcggaccgat tttcaagttt tgaggaagca gtcaaaggaa aagggaagtt 120
<210> 178
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 178
ccgattttca agttttgagg aagcagtcaa aggaaaaggg aagttaagag ctttatccat 60
tttgtttgag gtaatatata tacactttac actaatgtaa ttccttttta agtcacatta 120
<210> 179
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 179
ttatccaaat gttttattct ttttttagaa tgtgattctt ttttaacagg ttgggacaga 60
agaaaatttg gatttcaaag cgattattga tggagtcgaa agtgttagtc gttttggtaa 120
<210> 180
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 180
caggttggga cagaagaaaa tttggatttc aaagcgatta ttgatggagt cgaaagtgtt 60
agtcgttttg gtaagctact tggggaacta tctttcttca ggattctgct ttggatggat 120
<210> 181
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 181
aagttccagt gttgagattc cagctgagat gtatattatt cctttttagg gaagcaggct 60
gctttagatc cattcatact gttgaacctt ctgccaaact caactgacaa gtattacatt 120
<210> 182
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 182
tacaatggct cattgacatc tcctccctgc acagacacag ttgactggat tgtttttaaa 60
gatacagtta gcatctctga aagccaggta atcttagaaa ttcaaacaaa tcaagtaatt 120
<210> 183
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 183
atctcctccc tgcacagaca cagttgactg gattgttttt aaagatacag ttagcatctc 60
tgaaagccag gtaatcttag aaattcaaac aaatcaagta attcaaagcc atttaaaaaa 120
<210> 184
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 184
accaatgcct ttgaagcaga tatgttaaat tatttgatct ttttttcagt tggctgtttt 60
ttgtgaagtt cttacaatgc aacaatctgg ttatgtcatg ctgatggact acttacaaaa 120
<210> 185
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 185
caattttcga gagcaacagt acaagttctc tagacaggtg ttttcctcat acactggaaa 60
ggaagagatt catgaagcag gtatgtattt aaatataatc ttctacaact ctcatagatg 120
<210> 186
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 186
cagtgttata ggaggtaatt ttggtaaact gacaaatata gaggacttag agctttagaa 60
atgttttaat tattaatttt gtagctttag ataagctgtc taattttctg aatatcagat 120
<210> 187
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 187
accacatcta taaaatggca actaaaaaaa tctattcttc ccataagaat aaccccattt 60
tacagatgag aaaaactgag atttaataag gaaaatcatt tttccagaat acacagtaat 120
<210> 188
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 188
aagtagcaaa gcaaagtaca cacctccaag ttcactttct ggtatttgcc tgggctgaga 60
ggtatgagaa aggaatgaat aagaggctga ggtgttcaga gcttgggaga tcatttctgg 120
<210> 189
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 189
ttgggataat aaggaaaact ttatgggaga accgcctttg aactgagtct tgacacagta 60
tttgggtttt aaagtgctca tctttgtgtt ggcagccccc aagaaggagc ctagcacctt 120
<210> 190
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 190
atcagtactg aaaataaatg cactgagtta ttaatgaata agaagtgaat cttcttccca 60
gtttccttct ttggaggaaa agaaatttgc tctttttagg tacagccaag ggaaatgaca 120
<210> 191
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 191
ccagaggggt gtctctagaa tgccgtctgt tttttgaagc tgacacagta gttaaaagca 60
tttttaaatg tccagagaac acaatcagat acatctgctg acttgtcctt ttcagttttt 120
<210> 192
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 192
actgaggttg tcacttgttc attaaagaag tcgttgaagt gacctttgca ctggaaagga 60
cttctaacct ttccaagtag atggacctct ttgatatcag tcctgcaatg aattcaatga 120
<210> 193
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 193
tttttttttg ccatgtataa tattaattta ataatcatct gcttttgaag attaggcatt 60
aaaacaacaa gcttttattg ttttaatgtg atatttccaa gaatcgttta tcctttaaca 120
<210> 194
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 194
ttaggcatta aaacaacaag cttttattgt tttaatgtga tatttccaag aatcgtttat 60
cctttaacaa aaaaatagaa ttcaagacaa cagtgatgaa tagctatatt tactatgaca 120
<210> 195
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 195
gtcctcaagg ctaagttcta tcaacaactg tacttttttc tctctgaagt ttgtagttca 60
gaaccagaaa atgttcaggc tgacccagag aattatacca gccttcttgt tacatgggaa 120
<210> 196
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 196
agacctcgag tcgtttatga taccatgatt gagaagtttg cagttttgta ccagcagttg 60
gatggagagg accaaaccaa gcatgaattt ttgacagatg gctatcaaga cttggtaact 120
<210> 197
<211> 120
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 197
tttgtaccag cagttggatg gagaggacca aaccaagcat gaatttttga cagatggcta 60
tcaagacttg gtaactatat gatcagttgt tttacatagg gtaacattat aatttaattt 120
<210> 198
<211> 140
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 198
ccccgctgtg cttgcacctg gcatcctcgt gctcctgttt accttggtgc agaggagcaa 60
tggggagtgt aaagaggcac tagcaaagtc cgagatgaat gtgaatatga agtatcagct 120
tcccaacttc accgcggaaa 140
<210> 199
<211> 100
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 199
gtgaatatga agtatcagct tcccaacttc accgcggaaa cacccatcca gaatgtcatt 60
ctacatgagc atcacatttt ccttggtgcc actaactaca 100

Claims (3)

1. The application of the probe library in preparing a kit for detecting the fusion gene mutation of the MET family is characterized in that the probe library comprises all probes with nucleotide sequences shown in SEQ ID NO. 1-197.
2. The kit is characterized by comprising all probes with nucleotide sequences shown in SEQ ID NO. 1-197.
3. The kit of claim 2, further comprising: a DNA extraction reagent for extracting DNA of a sample to be detected; further comprises: the RNA extraction reagent is used for extracting mRNA of a sample to be detected; a reverse transcription kit for reverse transcribing the extracted mRNA into cDNA.
CN202210152016.9A 2022-02-18 2022-02-18 MET fusion gene detection method, kit and probe library Active CN114561467B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210152016.9A CN114561467B (en) 2022-02-18 2022-02-18 MET fusion gene detection method, kit and probe library

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210152016.9A CN114561467B (en) 2022-02-18 2022-02-18 MET fusion gene detection method, kit and probe library

Publications (2)

Publication Number Publication Date
CN114561467A CN114561467A (en) 2022-05-31
CN114561467B true CN114561467B (en) 2023-06-09

Family

ID=81713920

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210152016.9A Active CN114561467B (en) 2022-02-18 2022-02-18 MET fusion gene detection method, kit and probe library

Country Status (1)

Country Link
CN (1) CN114561467B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110331189A (en) * 2019-06-13 2019-10-15 南京世和基因生物技术有限公司 A kind of detection method, kit and the probe library of NTRK fusion
CN111020019A (en) * 2020-03-06 2020-04-17 元码基因科技(北京)股份有限公司 Method for gene fusion detection based on nanopore technology
WO2021041765A2 (en) * 2019-08-28 2021-03-04 An Hsu Kit and methods to detect ntrk gene fusion

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110331189A (en) * 2019-06-13 2019-10-15 南京世和基因生物技术有限公司 A kind of detection method, kit and the probe library of NTRK fusion
WO2021041765A2 (en) * 2019-08-28 2021-03-04 An Hsu Kit and methods to detect ntrk gene fusion
CN111020019A (en) * 2020-03-06 2020-04-17 元码基因科技(北京)股份有限公司 Method for gene fusion detection based on nanopore technology

Also Published As

Publication number Publication date
CN114561467A (en) 2022-05-31

Similar Documents

Publication Publication Date Title
KR102114412B1 (en) PREDICTING GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENs)
RU2668164C2 (en) Urine biomarker cohorts, gene expression signatures and methods of use thereof
KR101126560B1 (en) Process for predicting drug response
US20220389519A1 (en) Biomarkers predictive of anti-immune checkpoint response
CN107988362B (en) Lung cancer related 33 gene targeted capture sequencing kit and application thereof
KR20140006898A (en) Colon cancer gene expression signatures and methods of use
CN108138242A (en) Determine the method being mutated in genomic DNA, the purposes of this method and the kit for implementing this method
CN109423515B (en) Gene markers for liver cancer detection and application thereof
CN110719957A (en) Methods and kits for targeted enrichment of nucleic acids
KR102202726B1 (en) Markers for diagnostic or prognosis predictive of squamous cell carcinoma and uses thereof
CN106636344A (en) Thalassemia gene detection kit based on next generation high-throughput sequencing technology
CN111742061A (en) Pre-operative risk stratification based on PDE4D7 expression and pre-operative clinical variables
CN104561303A (en) Human tumor predictive biomarker compound and application thereof
CN114207153B (en) Methods and kits for screening colorectal neoplasms
AU742243B2 (en) Mammalian genes involved in viral infection and tumor suppression
CN114561467B (en) MET fusion gene detection method, kit and probe library
KR101783994B1 (en) A method for diagnosing a gastric cancer and a diagnostic kit using the method
KR101990953B1 (en) Method for Analyzing Aberrations of Cancer-Risk Genes
CN112391466A (en) Methylation biomarker for detecting breast cancer or combination and application thereof
CN110904230A (en) Method for in vitro diagnosis or prognosis of colon cancer
US20040091881A1 (en) Diagnosis of diseases which are associated with cd24
CN114410776B (en) Detection method and kit for NRG1 fusion gene
CN114908159A (en) Method and kit for screening, risk assessment and prognosis of colorectal advanced adenoma
CN112646895A (en) Primer, probe, kit, detection method and application for detecting gene expression level
CN108913761B (en) Kit for screening hereditary liver diseases

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant